In Stock, Royalty-Free, Reporter Plasmid
Aldevron, your trusted partner since 1998, has a reporter construct available at research grade, royalty and license free.
Benefits of pALD-CV77-Luciferase:
Aldevron's pALD-CV77-Luciferase reporter plasmid contains luciferase gene firefly Photinus pyralis and has several advantages:
- Royalty free for non-clinical research use
- Kanamycin resistance
- Consistent, reliable supply
- Immediately available at research grade
- Available in 100ug free sample vials, 5mg vials and 10mg vials, research grade only
| Description | Cat # | Price | Order |
|---|---|---|---|
|
pALD-CV77-Luciferase 10 mg |
5078-10 |
pALD-CV77-Luciferase 10 mg Pricing
|
|
|
pALD-CV77-Luciferase 5 mg |
5078-5 |
pALD-CV77-Luciferase 5 mg Pricing
|
*Not for human use or medical diagnostic use.
pALD-CV77-Luciferase Reporters Quality Control Specifications
| Appearance | Clear and Colorless |
| Buffer | TE |
| Bioburden | No growth in 48 hours at 37 +/- 2 C |
| Concentration | 1.0mg/mL +/- 10% |
| DNA Homogeneity | ≥80% Supercoiled |
| Endotoxin | ≤100 EU/mg |
| Identity | Confirmed Against DNA Ladder |
| Plasmid Identity | Identical to Reference Sequence |
| ABS 260/280 Ratio Purity | 1.80 – 2.00 |
| Residual Host Genomic DNA via qPCR | ≤5% |
| Residual Host Protein via BCA | ≤2% |
| Residual Host RNA via SYBR Gold | ≤5% by Semi-Quantitative Densitometry |
| Restriction Digest | Matches Expected Restriction Pattern |
| Mycoplasma Contamination | Negative for the Presence of Mycoplasma |